Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Injection Interval for Intra-Detrusor Botulinum Toxin: A Randomized Controlled Trial Utilizing a Patient-Centered Approach

NCT06483217 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT06483217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06483217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin: A Randomized Controlled Trial Utilizing a Patient-Centered Approach
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2024
Completion date
October 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urge urinary incontinence, urinary incontinence, urinary urgency